Point of care testing for improving risk- benefit ratio of aspirin and warfarin
Mol Cytogenet
.
2014 Jan 21;7(Suppl 1 Proceedings of the International Conference on Human):I54.
doi: 10.1186/1755-8166-7-S1-I54.
eCollection 2014.
Authors
Harsh Sheth
1
,
Emma Northwood
2
,
Faye Elliott
2
,
Michael Jackson
1
,
Mauro Santibanez Koref
1
,
John Tyson
3
,
Ann Daly
4
,
Jonathan O'Halloran
3
,
Jayesh Sheth
5
,
Frenny Sheth
5
,
Keyur Parikh
6
,
D Timothy Bishop
2
,
John Burn
1
Affiliations
1
Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
2
Leeds Institute of Molecular Medicine, St. James Hospital, Beckett Street, Leeds, UK.
3
QuantuMDx Ltd., International Centre for Life, Newcastle upon Tyne, UK.
4
Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
5
FRIGE's Institute of Human Genetics, FRIGE House, Satellite, Ahmedabad, India.
6
CIMS Hospital, Nr. Shakun Mall, Sola, Ahmedabad, India.
PMID:
24949102
PMCID:
PMC4044298
DOI:
10.1186/1755-8166-7-S1-I54
No abstract available
Grants and funding
10589/CRUK_/Cancer Research UK/United Kingdom
15934/CRUK_/Cancer Research UK/United Kingdom